I have a background in molecular pharmacology and therapeutics laboratory research, especially studies of the molecular mechanisms of drug resistance. I believe that understanding the fundamental biology of cancer is vital to our ability to improve cancer treatment. The work we’ve done in the laboratory and its translation to improve the treatment of lymphoma is now being applied to the care of children with other types of cancer. This is very satisfying for me, and serves as a tribute to the patients we’ve treated. Research enables us to provide options when no others are available and gives parents hope.
I am involved on the national level in the Children’s Oncology Group, where I serve as Chairperson of the Hodgkin’s Biology Committee and Vice Chair of the Hodgkin’s Disease Committee. I also teach fellows and have mentored several who have gone on to start their own research programs, and I am very proud to help them start their careers. I have received several awards for my work, including being named a Diamond Member of the International Association of Pediatricians and The Leading Physicians of the World in 2010.
It is very gratifying when I see patients conquer cancer and go on to do well. I understand how critical research is to advancing the treatment of cancer, and it is rewarding to know that the investigations I am leading may save the life of a child.